Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force-Reference-Cited by-同舟云学术

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

Published:2017-02 Issue:2 Volume:28 Page:218-227
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Stauder R.,Eichhorst B.,Hamaker M.E.,Kaplanov K.,Morrison V.A.,Österborg A.,Poddubnaya I.,Woyach J.A.,Shanafelt T.,Smolej L.,Ysebaert L.,Goede V.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/2/218/13789926/mdw547.pdf

Reference109 articles.

1. Pattern of leukemia in the United States by subtype and demographic characteristics;Yamamoto;Cancer Causes Control,2008

2. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project;Sant;Blood,2010

3. http://seer.cancer.gov/accessed (26 September 2016, date last accessed).

4. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France;Monnereau;Int J Cancer,2013

5. Survival for patients with chronic leukemias in the US and Britain: age-related disparities and changes in the early 21st century;Pulte;Eur J Haematol,2015

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geriatric assessment for the practicing clinician: The why, what, and how;CA: A Cancer Journal for Clinicians;2024-08-29

2. Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor–Based Regimens in the Second-Line Setting;JCO Oncology Practice;2024-08

3. Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton’s tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting;Journal of Managed Care & Specialty Pharmacy;2024-07-24

4. Management der kardiovaskulären Medikation während der CLL-Therapie;InFo Hämatologie + Onkologie;2024-07

5. The Looming Cancer: A Qualitative Study on the Experience of Living with Chronic Lymphocytic Leukemia (CLL) before the Initiation of Treatment;European Journal of Cancer Care;2024-02-28